Dr. Michael Palfreyman is a highly accomplished pharmaceutical executive with over four decades of experience in drug discovery and development.

Previously, Michael held leadership roles at companies including EnVivo Pharmaceuticals (now Forum Pharmaceuticals) and Scriptgen Pharmaceuticals (now Anadys Pharmaceuticals). He also served in executive positions at Marion Merrell Dow (now Sanofi) and Beecham Pharmaceuticals (now GlaxoSmithKline). Palfreyman's educational background includes degrees from the University of Nottingham, and he has co-invented numerous patents and authored over 150 scientific articles and book chapters.

Michael oversees research and development diligence at Torrey Pines Investment Ventures.